Connection

NANCY WEBB to Animals

This is a "connection" page, showing publications NANCY WEBB has written about Animals.
Connection Strength

0.688
  1. High-Density Lipoproteins and Serum Amyloid A (SAA). Curr Atheroscler Rep. 2021 01 15; 23(2):7.
    View in: PubMed
    Score: 0.039
  2. Serum amyloid A is not incorporated into HDL during HDL biogenesis. J Lipid Res. 2020 03; 61(3):328-337.
    View in: PubMed
    Score: 0.036
  3. High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation. J Biol Chem. 2018 08 24; 293(34):13257-13269.
    View in: PubMed
    Score: 0.032
  4. Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein. J Lipid Res. 2018 02; 59(2):339-347.
    View in: PubMed
    Score: 0.031
  5. The dual role of group V secretory phospholipase A2 in pancreatic ?-cells. Endocrine. 2017 Oct; 58(1):47-58.
    View in: PubMed
    Score: 0.030
  6. Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation. Arterioscler Thromb Vasc Biol. 2015 May; 35(5):1156-65.
    View in: PubMed
    Score: 0.026
  7. Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis. J Biol Chem. 2015 Mar 20; 290(12):7851-60.
    View in: PubMed
    Score: 0.026
  8. Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism. J Biol Chem. 2014 Oct 03; 289(40):27410-7.
    View in: PubMed
    Score: 0.025
  9. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation. 2013 Sep 10; 128(11):1256-67.
    View in: PubMed
    Score: 0.023
  10. Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice. Am J Pathol. 2012 Sep; 181(3):1088-98.
    View in: PubMed
    Score: 0.021
  11. Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase. J Lipid Res. 2011 Dec; 52(12):2255-2261.
    View in: PubMed
    Score: 0.020
  12. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages. Arterioscler Thromb Vasc Biol. 2010 Oct; 30(10):2014-21.
    View in: PubMed
    Score: 0.019
  13. Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. Atherosclerosis. 2011 Jan; 214(1):58-64.
    View in: PubMed
    Score: 0.019
  14. Group X secretory phospholipase A2 negatively regulates adipogenesis in murine models. FASEB J. 2010 Nov; 24(11):4313-24.
    View in: PubMed
    Score: 0.019
  15. Group X secretory phospholipase A2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands. J Biol Chem. 2010 Jun 25; 285(26):20031-9.
    View in: PubMed
    Score: 0.018
  16. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Arterioscler Thromb Vasc Biol. 2009 Apr; 29(4):532-8.
    View in: PubMed
    Score: 0.017
  17. Biology of secretory phospholipase A2. Cardiovasc Drugs Ther. 2009 Feb; 23(1):61-72.
    View in: PubMed
    Score: 0.017
  18. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res. 2007 Dec; 48(12):2560-70.
    View in: PubMed
    Score: 0.015
  19. HDL cholesterol transport during inflammation. Curr Opin Lipidol. 2007 Apr; 18(2):147-51.
    View in: PubMed
    Score: 0.015
  20. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol. 2007 Mar; 27(3):600-6.
    View in: PubMed
    Score: 0.015
  21. Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundant. Arterioscler Thromb Vasc Biol. 2006 Jul; 26(7):1421-2.
    View in: PubMed
    Score: 0.014
  22. Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts. J Lipid Res. 2006 Aug; 47(8):1700-13.
    View in: PubMed
    Score: 0.014
  23. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J Biol Chem. 2005 Sep 23; 280(38):32746-52.
    View in: PubMed
    Score: 0.013
  24. Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation. Atherosclerosis. 2024 04; 391:117492.
    View in: PubMed
    Score: 0.012
  25. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler Thromb Vasc Biol. 2004 Apr; 24(4):762-7.
    View in: PubMed
    Score: 0.012
  26. Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice. Int J Mol Sci. 2023 Dec 15; 24(24).
    View in: PubMed
    Score: 0.012
  27. Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein. J Lipid Res. 2023 05; 64(5):100365.
    View in: PubMed
    Score: 0.011
  28. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):263-8.
    View in: PubMed
    Score: 0.011
  29. Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice. J Lipid Res. 2002 Sep; 43(9):1421-8.
    View in: PubMed
    Score: 0.011
  30. Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications. PLoS One. 2022; 17(4):e0266688.
    View in: PubMed
    Score: 0.011
  31. Adipocyte-Derived Serum Amyloid A Promotes Angiotensin II-Induced Abdominal Aortic Aneurysms in Obese C57BL/6J Mice. Arterioscler Thromb Vasc Biol. 2022 05; 42(5):632-643.
    View in: PubMed
    Score: 0.010
  32. Aortic Aneurysms and Dissections Series. Arterioscler Thromb Vasc Biol. 2020 03; 40(3):e37-e46.
    View in: PubMed
    Score: 0.009
  33. American Heart Association Vascular Disease Strategically Focused Research Network. Arterioscler Thromb Vasc Biol. 2020 03; 40(3):e47-e54.
    View in: PubMed
    Score: 0.009
  34. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019 03; 567(7747):249-252.
    View in: PubMed
    Score: 0.008
  35. Serum Amyloid A Is an Exchangeable Apolipoprotein. Arterioscler Thromb Vasc Biol. 2018 08; 38(8):1890-1900.
    View in: PubMed
    Score: 0.008
  36. Serum amyloid A3 is pro-atherogenic. Atherosclerosis. 2018 01; 268:32-35.
    View in: PubMed
    Score: 0.008
  37. Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer. Cell Stem Cell. 2016 07 07; 19(1):38-51.
    View in: PubMed
    Score: 0.007
  38. Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice. J Lipid Res. 2016 06; 57(6):969-79.
    View in: PubMed
    Score: 0.007
  39. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J Lipid Res. 2015 Feb; 56(2):286-93.
    View in: PubMed
    Score: 0.006
  40. Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling. Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):1910-6.
    View in: PubMed
    Score: 0.006
  41. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2):255-61.
    View in: PubMed
    Score: 0.006
  42. Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. J Lipid Res. 2012 Mar; 53(3):446-455.
    View in: PubMed
    Score: 0.005
  43. SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL. Arterioscler Thromb Vasc Biol. 2009 Sep; 29(9):1298-303.
    View in: PubMed
    Score: 0.004
  44. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am J Pathol. 2008 Dec; 173(6):1902-10.
    View in: PubMed
    Score: 0.004
  45. SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism. J Lipid Res. 2005 Oct; 46(10):2143-50.
    View in: PubMed
    Score: 0.003
  46. Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis. J Lipid Res. 2005 Sep; 46(9):1812-22.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.